Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis

Free Subscription 13.01.2020 2 Am J Gastroenterol 1 BMC Cancer 1 BMC Gastroenterol 1 Clin Infect Dis 1 Dtsch Med Wochenschr 3 Eur J Gastroenterol Hepatol 1 Gastroenterol Hepatol 1 Gastroenterology 2 Gut 1 J Hepatol 1 J Infect Dis 3 J Viral Hepat 1 J Virol 9 PLoS One 1 Proc Natl Acad Sci U S A 1 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. HSU YC, Nguyen MH
   Inhibitory Effect of Nucleos(t)ide Analogs on Telomerase Activity and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
   Am J Gastroenterol. 2020 Jan 6. doi: 10.14309/ajg.0000000000000507.
   PubMed     Text format    
   
   
2. CHOI J, Kim GA, Han S, Lim YS, et al
   Earlier Alanine Aminotransferase Normalization During Antiviral Treatment Is Independently Associated With Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B.
   Am J Gastroenterol. 2020 Jan 2. doi: 10.14309/ajg.0000000000000490.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

3. HUANG FY, Wong DK, Tsui VW, Seto WK, et al
   Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
   BMC Cancer. 2019;19:789.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

4. LIAO YH, Hsu RJ, Wang TH, Wu CT, et al
   Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
   BMC Gastroenterol. 2020;20:6.
   PubMed     Text format     Abstract available
   
   

   
   Clin Infect Dis

5. FARAG MS, van Campenhout MJH, Pfefferkorn M, Fischer J, et al
   Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B.
   Clin Infect Dis. 2020 Jan 8. pii: 5698122. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Dtsch Med Wochenschr

6. RIFAIE N, Saner FH
   [Treatment of Fulminant Hepatic Failure - Myth and Facts].
   Dtsch Med Wochenschr. 2019;144:1034-1039.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

7. GAO X, Duan X, Cai H, Hu Y, et al
   The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B.
   Eur J Gastroenterol Hepatol. 2019 Dec 31. doi: 10.1097/MEG.0000000000001662.
   PubMed     Text format     Abstract available
   
   
8. HASSANIN TM, Abdelraheem EM, Abdelhameed S, Abdelrazik M, et al
   Detection of hepatitis C virus core antigen as an alternative method for diagnosis of hepatitis C virus infection in blood donors negative for hepatitis C virus antibody.
   Eur J Gastroenterol Hepatol. 2019 Dec 31. doi: 10.1097/MEG.0000000000001647.
   PubMed     Text format     Abstract available
   
   
9. RAMACHANDRAN J, Kaambwa B, Muller K, Haridy J, et al
   Cost effectiveness of treatment models of care for hepatitis C: the South Australian state-wide experience.
   Eur J Gastroenterol Hepatol. 2019 Dec 31. doi: 10.1097/MEG.0000000000001659.
   PubMed     Text format     Abstract available
   
   

   
   Gastroenterol Hepatol

10. SASTRE L, Garcia-Lopez M, Perez-Del-Pulgar S, Lens S, et al
    The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy.
    Gastroenterol Hepatol. 2020 Jan 2. pii: S0210-5705(19)30140.
    PubMed     Text format    
    
    

    
    Gastroenterology

11. KAMBOJ AK, Bledsoe AC, Arora AS
    A Slow and Distended Stomach.
    Gastroenterology. 2019;157:1485-1486.
    PubMed     Text format    
    
    

    
    Gut

12. OECHSLIN N, Moradpour D, Gouttenoire J
    Hepatitis E virus finds its path through the gut.
    Gut. 2020 Jan 8. pii: gutjnl-2019-320206. doi: 10.1136/gutjnl-2019-320206.
    PubMed     Text format    
    
    
13. BESOMBES C, Njouom R, Paireau J, Lachenal G, et al
    The epidemiology of hepatitis delta virus infection in Cameroon.
    Gut. 2020 Jan 6. pii: gutjnl-2019-320027. doi: 10.1136/gutjnl-2019-320027.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

14. EVON DM, Sarkar S, Amador J, Lok AS, et al
    Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".
    J Hepatol. 2019 Dec 27. pii: S0168-8278(19)30702.
    PubMed     Text format    
    
    

    
    J Infect Dis

15. CLIPMAN SJ, Duggal P, Srikrishnan AK, Saravanan S, et al
    Prevalence and phylogenetic characterization of hepatitis C among men who have sex with men in India: limited evidence for sexual transmission.
    J Infect Dis. 2020 Jan 9. pii: 5699640. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    J Viral Hepat

16. FEDORCHENKO SV, Martynovych T, Klimenko Z, Yanchenko V, et al
    Retreatment of patients with chronic hepatitis C, subtype 1b and cirrhosis, who failed previous direct acting antiviral therapy including first- and second-generation NS5A inhibitors with ombitasvir/ paritaprevir/ ritonavir, dasabuvir + sofosbuvir + r
    J Viral Hepat. 2020 Jan 2. doi: 10.1111/jvh.13254.
    PubMed     Text format     Abstract available
    
    
17. YAMAMICHI S, Miuma S, Wada T, Masumoto H, et al
    Deep sequence analysis of NS5A resistance-associated substitution changes in patients reinfected with the hepatitis C virus after liver transplantation.
    J Viral Hepat. 2020 Jan 2. doi: 10.1111/jvh.13256.
    PubMed     Text format     Abstract available
    
    
18. TRAM J, Le Baccon-Sollier P, Bollore K, Ducos J, et al
    RNA testing for the diagnosis of acute hepatitis A during the 2017 outbreak in France.
    J Viral Hepat. 2020 Jan 2. doi: 10.1111/jvh.13255.
    PubMed     Text format     Abstract available
    
    

    
    J Virol

19. KHAKPOOR A, Ni Y, Chen A, Ho ZZ, et al
    Spatiotemporal Differences in Presentation of CD8 T Cell Epitopes during Hepatitis B Virus Infection.
    J Virol. 2019;93.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

20. WEITZEL T, Rodriguez F, Noriega LM, Marcotti A, et al
    Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey.
    PLoS One. 2020;15:e0227776.
    PubMed     Text format     Abstract available
    
    
21. NUTINI MFR, Hunter J, Giron L, Pires AFNPC, et al
    HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country.
    PLoS One. 2020;15:e0227082.
    PubMed     Text format     Abstract available
    
    
22. GOOD SS, Moussa A, Zhou XJ, Pietropaolo K, et al
    Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virus.
    PLoS One. 2020;15:e0227104.
    PubMed     Text format     Abstract available
    
    
23. GANTNER P, Cotte L, Allavena C, Bani-Sadr F, et al
    Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.
    PLoS One. 2019;14:e0215464.
    PubMed     Text format     Abstract available
    
    
24. SHAO LN, Zhang ST, Wang N, Yu WJ, et al
    Platelet indices significantly correlate with liver fibrosis in HCV-infected patients.
    PLoS One. 2020;15:e0227544.
    PubMed     Text format     Abstract available
    
    
25. TSAI WL, Wang CF, Cheng JS, Chen WC, et al
    Sofosbuvir-based regimen for genotype 2 HCV infected patients in Taiwan: A real world experience.
    PLoS One. 2020;15:e0227424.
    PubMed     Text format     Abstract available
    
    
26. HAMDI M, Abdel-Bar HM, Elmowafy E, Al-Jamal KT, et al
    An integrated vitamin E-coated polymer hybrid nanoplatform: A lucrative option for an enhanced in vitro macrophage retention for an anti-hepatitis B therapeutic prospect.
    PLoS One. 2020;15:e0227231.
    PubMed     Text format     Abstract available
    
    
27. RIVERO-JUAREZ A, Guijo-Rubio D, Tellez F, Palacios R, et al
    Using machine learning methods to determine a typology of patients with HIV-HCV infection to be treated with antivirals.
    PLoS One. 2020;15:e0227188.
    PubMed     Text format     Abstract available
    
    
28. ABGHOUR S, Zro K, Mouahid M, Tahiri F, et al
    Isolation and characterization of fowl aviadenovirus serotype 11 from chickens with inclusion body hepatitis in Morocco.
    PLoS One. 2019;14:e0227004.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

29. TODT D, Friesland M, Moeller N, Praditya D, et al
    Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
    Proc Natl Acad Sci U S A. 2020 Jan 2. pii: 1912307117.
    PubMed     Text format     Abstract available
    
    

    
    Transplant Proc

30. BAYRAKTAR A, Akgul SU, Bakkaloglu H, Temurhan S, et al
    Can Direct-Acting Antiviral Treatment Change the Immunologic Risk Profile in Patients Infected with Hepatitis C Virus Who Are on the Cadaveric Waiting List?
    Transplant Proc. 2019 Dec 31. pii: S0041-1345(19)30884.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: